SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-17-002417
Filing Date
2017-11-14
Accepted
2017-11-14 16:43:08
Documents
46
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nemus_10q.htm 10-Q 328606
2 CERTIFICATION nemus_ex311.htm EX-31.1 7443
3 CERTIFICATION nemus_ex312.htm EX-31.2 7493
4 CERTIFICATION nemus_ex321.htm EX-32.1 2684
5 CERTIFICATION nemus_ex322.htm EX-32.2 2696
  Complete submission text file 0001640334-17-002417.txt   3159599

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nmus-20170930.xml EX-101.INS 571860
7 XBRL TAXONOMY EXTENSION SCHEMA nmus-20170930.xsd EX-101.SCH 40020
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nmus-20170930_cal.xml EX-101.CAL 30854
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nmus-20170930_def.xml EX-101.DEF 164300
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nmus-20170930_lab.xml EX-101.LAB 337453
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nmus-20170930_pre.xml EX-101.PRE 234995
Mailing Address 600 ANTON BLVD, SUITE 1100 COSTA MESA CA 92626
Business Address 600 ANTON BLVD, SUITE 1100 COSTA MESA CA 92626 (949) 396-0330
Nemus Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55136 | Film No.: 171202319
SIC: 2834 Pharmaceutical Preparations